NasdaqGM - Delayed Quote USD

ProShares Ultra Nasdaq Biotechnology (BIB)

49.66 +0.72 (+1.47%)
At close: April 26 at 4:00 PM EDT

ETF Summary

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Risk Overview

Performance & Risk

YTD Return -12.89%
5y Average Return -0.42%
Rank in Category (ytd) --
% Rank in Category (ytd) --
Beta (5Y Monthly) 1.31
Morningstar Risk Rating --

Risk Statistics

3 Years5 Years10 Years
BIBCategory AverageBIBCategory AverageBIBCategory Average
Alpha -21.92 -- -12.93 -- -10.19 --
BETA 1.31 -- 1.38 -- 1.79 --
Mean Annual Return -0.55 -- 0.67 -- 1.05 --
R-squared 44.66 -- 42.15 -- 41.76 --
Standard Deviation 34.35 -- 38.95 -- 41.99 --
Sharpe Ratio -0.28 -- 0.15 -- 0.27 --
Treynor Ratio -11.17 -- -0.99 -- 1.26 --

Related Tickers